{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T23:45:03Z","timestamp":1782863103903,"version":"3.54.5"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Endosc"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s00464-026-12707-7","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T16:40:00Z","timestamp":1772815200000},"page":"4184-4194","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cost-effectiveness analysis of laparoscopic versus open distal gastrectomy for locally advanced gastric cancer based on TNM stage: a Markov model"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0637-9288","authenticated-orcid":false,"given":"Min","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhen","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"issue":"10251","key":"12707_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F (2020) Gastric cancer. Lancet (Lond, Engl) 396(10251):635\u2013648","journal-title":"Lancet (Lond, Engl)"},{"issue":"12","key":"12707_CR2","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1200\/JCO.2015.63.7215","volume":"34","author":"Y Hu","year":"2016","unstructured":"Hu Y, Huang C, Sun Y, Su X, Cao H, Hu J, Xue Y, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Chen P, Liu H, Zheng C, Liu F, Yu J, Li Z, Zhao G, Chen X, Wang K, Li P, Xing J, Li G (2016) Morbidity and mortality of laparoscopic versus open D2 distal gastrectomy for advanced gastric cancer: a randomized controlled trial. J Clin Oncol 34(12):1350\u20131357","journal-title":"J Clin Oncol"},{"issue":"20","key":"12707_CR3","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1001\/jama.2019.5359","volume":"321","author":"J Yu","year":"2019","unstructured":"Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Hu Y, Liu H, Zheng C, Li P, Xie J, Liu F, Li Z, Zhao G, Yang K, Liu C, Li H, Chen P, Ji J, Li G (2019) Effect of laparoscopic vs open distal gastrectomy on 3-year disease-free survival in patients with locally advanced gastric cancer: the CLASS-01 randomized clinical trial. JAMA 321(20):1983\u20131992","journal-title":"JAMA"},{"issue":"1","key":"12707_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamasurg.2021.5104","volume":"157","author":"C Huang","year":"2022","unstructured":"Huang C, Liu H, Hu Y, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Yu J, Zheng C, Liu F, Li Z, Zhao G, Zhang J, Chen P, Li G (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: five-year outcomes from the CLASS-01 randomized clinical trial. JAMA Surg 157(1):9\u201317","journal-title":"JAMA Surg"},{"issue":"5","key":"12707_CR5","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jamasurg.2023.0096","volume":"158","author":"T Etoh","year":"2023","unstructured":"Etoh T, Ohyama T, Sakuramoto S, Tsuji T, Lee SW, Yoshida K, Koeda K, Hiki N, Kunisaki C, Tokunaga M, Otsubo D, Takagane A, Misawa K, Kinoshita T, Cho H, Doki Y, Nunobe S, Shiraishi N, Kitano S (2023) Five-year survival outcomes of laparoscopy-assisted vs open distal gastrectomy for advanced gastric cancer: the JLSSG0901 randomized clinical trial. JAMA Surg 158(5):445\u2013454","journal-title":"JAMA Surg"},{"issue":"10","key":"12707_CR6","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1001\/jamasurg.2022.2749","volume":"157","author":"SY Son","year":"2022","unstructured":"Son SY, Hur H, Hyung WJ, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Yang HK, Han SU (2022) Laparoscopic vs open distal gastrectomy for locally advanced gastric cancer: 5-year outcomes of the KLASS-02 randomized clinical trial. JAMA Surg 157(10):879\u2013886","journal-title":"JAMA Surg"},{"issue":"28","key":"12707_CR7","doi-asserted-by":"publisher","first-page":"3304","DOI":"10.1200\/JCO.20.01210","volume":"38","author":"WJ Hyung","year":"2020","unstructured":"Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Han SU (2020) Long-term outcomes of laparoscopic distal gastrectomy for locally advanced gastric cancer: the KLASS-02-RCT randomized clinical trial. J Clin Oncol 38(28):3304\u20133313","journal-title":"J Clin Oncol"},{"issue":"6","key":"12707_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1097\/SLA.0000000000003217","volume":"270","author":"HJ Lee","year":"2019","unstructured":"Lee HJ, Hyung WJ, Yang HK, Han SU, Park YK, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Kim MC (2019) Short-term outcomes of a multicenter randomized controlled trial comparing laparoscopic distal gastrectomy with D2 lymphadenectomy to open distal gastrectomy for locally advanced gastric cancer (KLASS-02-RCT). Ann Surg 270(6):983\u2013991","journal-title":"Ann Surg"},{"issue":"9","key":"12707_CR9","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1200\/JCO.20.01540","volume":"39","author":"A van der Veen","year":"2021","unstructured":"van der Veen A, Brenkman HJF, Seesing MFJ, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, Stoot J, Tegels JJW, Wijnhoven BPL, Lagarde SM, de Steur WO, Hartgrink HH, Kouwenhoven EA, Wassenaar EB, Draaisma WA, Gisbertz SS, van der Peet DL, May AM, Ruurda JP, van Hillegersberg R (2021) Laparoscopic versus open gastrectomy for gastric cancer (LOGICA): a multicenter randomized clinical trial. J Clin Oncol 39(9):978\u2013989","journal-title":"J Clin Oncol"},{"issue":"2","key":"12707_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1001\/jamasurg.2022.6337","volume":"158","author":"A van der Veen","year":"2023","unstructured":"van der Veen A, van der Meulen MP, Seesing MFJ, Brenkman HJF, Haverkamp L, Luyer MDP, Nieuwenhuijzen GAP, Stoot J, Tegels JJW, Wijnhoven BPL, Lagarde SM, de Steur WO, Hartgrink HH, Kouwenhoven EA, Wassenaar EB, Draaisma WA, Gisbertz SS, van der Peet DL, van Laarhoven HWM, Frederix GWJ, Ruurda JP, van Hillegersberg R (2023) Cost-effectiveness of laparoscopic vs open gastrectomy for gastric cancer: an economic evaluation alongside a randomized clinical trial. JAMA Surg 158(2):120\u2013128","journal-title":"JAMA Surg"},{"issue":"5","key":"12707_CR11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/bjs5.50327","volume":"4","author":"A Gosselin-Tardif","year":"2020","unstructured":"Gosselin-Tardif A, Abou-Khalil M, Mata J, Guigui A, Cools-Lartigue J, Ferri L, Lee L, Mueller C (2020) Laparoscopic versus open subtotal gastrectomy for gastric adenocarcinoma: cost-effectiveness analysis. BJS Open 4(5):830\u2013839","journal-title":"BJS Open"},{"issue":"10","key":"12707_CR12","doi-asserted-by":"publisher","first-page":"7472","DOI":"10.1007\/s00464-023-10147-1","volume":"37","author":"J Lu","year":"2023","unstructured":"Lu J, Wu D, Huang JB, Lin J, Xu BB, Xue Z, Zheng HL, Lin GS, Shen LL, Li P, Wang JB, Lin JX, Chen QY, Cao LL, Xie JW, Zheng CH, Huang CM (2023) Comparison of robotic versus laparoscopic versus open distal gastrectomy for locally advanced gastric cancer: a prospective trial-based economic evaluation. Surg Endosc 37(10):7472\u20137485","journal-title":"Surg Endosc"},{"issue":"1","key":"12707_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-91003-1","volume":"15","author":"M Lai","year":"2025","unstructured":"Lai M, Li Y, Lan N, Yuan W (2025) Cost-effectiveness of open vs. laparoscopic gastrectomy for locally advanced gastric cancer in China. Sci Rep 15(1):6714","journal-title":"Sci Rep"},{"issue":"7","key":"12707_CR14","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1245\/s10434-009-0473-x","volume":"16","author":"JF Lai","year":"2009","unstructured":"Lai JF, Kim S, Kim K, Li C, Oh SJ, Hyung WJ, Rha SY, Chung HC, Choi SH, Wang LB, Noh SH (2009) Prediction of recurrence of early gastric cancer after curative resection. Ann Surg Oncol 16(7):1896\u20131902","journal-title":"Ann Surg Oncol"},{"issue":"10","key":"12707_CR15","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1001\/jama.2016.12195","volume":"316","author":"GD Sanders","year":"2016","unstructured":"Sanders GD, Neumann PJ, Basu A, Brock DW, Feeny D, Krahn M, Kuntz KM, Meltzer DO, Owens DK, Prosser LA, Salomon JA, Sculpher MJ, Trikalinos TA, Russell LB, Siegel JE, Ganiats TG (2016) Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA 316(10):1093\u20131103","journal-title":"JAMA"},{"key":"12707_CR16","unstructured":"ISPOR (n.d.) Pharmacoeconomic guidelines: China mainland. https:\/\/www.ispor.org\/heor-resources\/more-heor-resources\/pharmacoeconomic-guidelines\/pe-guideline-detail\/china-mainland. Accessed 22 Mar 2025."},{"key":"12707_CR17","unstructured":"National Bureau of Statistics of China (n.d.) Yearbook. https:\/\/www.stats.gov.cn\/english\/Statisticaldata\/yearbook\/. Accessed 20 Oct 2024"},{"key":"12707_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/17588359231171038","volume":"15","author":"X Cao","year":"2023","unstructured":"Cao X, Zhang M, Li N, Zheng B, Liu M, Song X, Cai H (2023) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric cancer, gastroesophageal junction cancer, and esophageal adenocarcinoma: a cost-effectiveness analysis. Ther Adv Med Oncol 15:17588359231171038","journal-title":"Ther Adv Med Oncol"},{"issue":"10294","key":"12707_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, Wyrwicz L, Yamaguchi K, Skoczylas T, Campos Bragagnoli A, Liu T, Schenker M, Yanez P, Tehfe M, Kowalyszyn R, Karamouzis MV, Bruges R, Zander T, Pazo-Cid R, Hitre E, Feeney K, Cleary JM, Poulart V, Cullen D, Lei M, Xiao H, Kondo K, Li M, Ajani JA (2021) First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (checkmate 649): a randomised, open-label, phase 3 trial. Lancet (Lond, Engl) 398(10294):27\u201340","journal-title":"Lancet (Lond, Engl)"},{"issue":"10418","key":"12707_CR20","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/S0140-6736(23)02033-0","volume":"402","author":"YY Janjigian","year":"2023","unstructured":"Janjigian YY, Kawazoe A, Bai Y, Xu J, Lonardi S, Metges JP, Yanez P, Wyrwicz LS, Shen L, Ostapenko Y, Bilici M, Chung HC, Shitara K, Qin SK, Van Cutsem E, Tabernero J, Li K, Shih CS, Bhagia P, Rha SY (2023) Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 keynote-811 randomised placebo-controlled trial. Lancet 402(10418):2197\u20132208","journal-title":"Lancet"},{"issue":"9742","key":"12707_CR21","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, R\u00fcschoff J, Kang YK (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742):687\u2013697","journal-title":"Lancet"},{"issue":"1","key":"12707_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2024","unstructured":"Wang FH, Zhang XT, Tang L, Wu Q, Cai MY, Li YF, Qu XJ, Qiu H, Zhang YJ, Ying JE, Zhang J, Sun LY, Lin RB, Wang C, Liu H, Qiu MZ, Guan WL, Rao SX, Ji JF, Xin Y, Sheng WQ, Xu HM, Zhou ZW, Zhou AP, Jin J, Yuan XL, Bi F, Liu TS, Liang H, Zhang YQ, Li GX, Liang J, Liu BR, Shen L, Li J, Xu RH (2024) The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun (Lond, Engl) 44(1):127\u2013172","journal-title":"Cancer Commun (Lond, Engl)"},{"issue":"1","key":"12707_CR23","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2482019","volume":"57","author":"K Xu","year":"2025","unstructured":"Xu K, Yu M, Sun Q, Zhang L, Qian X, Su D, Gong J, Shang J, Lin Y, Li X (2025) Cost-effectiveness of PD-1 inhibitors combined with chemotherapy for first-line treatment of oesophageal squamous cell carcinoma in China: a comprehensive analysis. Ann Med 57(1):2482019","journal-title":"Ann Med"},{"key":"12707_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-12-9","volume":"12","author":"P Guyot","year":"2012","unstructured":"Guyot P, Ades AE, Ouwens MJ, Welton NJ (2012) Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 12:9","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"12707_CR25","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s10198-021-01335-8","volume":"22","author":"MM Pourrahmat","year":"2021","unstructured":"Pourrahmat MM, Kim A, Kansal AR, Hux M, Pushkarna D, Fazeli MS, Chung KC (2021) Health state utility values by cancer stage: a systematic literature review. Eur J Health Econ 22(8):1275\u20131288","journal-title":"Eur J Health Econ"},{"issue":"3","key":"12707_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1530\/EJE-15-0454","volume":"173","author":"BH Lang","year":"2015","unstructured":"Lang BH, Wong CK (2015) A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma. Eur J Endocrinol 173(3):367\u2013375","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"12707_CR27","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1097\/SLA.0000000000004466","volume":"273","author":"J Lu","year":"2021","unstructured":"Lu J, Zheng CH, Xu BB, Xie JW, Wang JB, Lin JX, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Lin JL, Zheng HL, Huang CM, Li P (2021) Assessment of robotic versus laparoscopic distal gastrectomy for gastric cancer: a randomized controlled trial. Ann Surg 273(5):858\u2013867","journal-title":"Ann Surg"},{"key":"12707_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221122733","volume":"14","author":"X Cao","year":"2022","unstructured":"Cao X, Cai H, Li N, Zheng B, Zheng Z, Liu M (2022) First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone for advanced esophageal cancer: a cost-effectiveness analysis. Ther Adv Med Oncol 14:17588359221122733","journal-title":"Ther Adv Med Oncol"},{"key":"12707_CR29","unstructured":"Centers for Medicare & Medicaid Services (n.d.) 2022 ASP drug pricing files. https:\/\/www.cms.gov\/medicare\/medicare-part-b-drug-average-sales-price\/2022-asp-drug-pricing-files"},{"issue":"4","key":"12707_CR30","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jval.2018.11.014","volume":"22","author":"LP Garrison Jr.","year":"2019","unstructured":"Garrison LP Jr., Babigumira J, Tournier C, Goertz HP, Lubinga SJ, Perez EA (2019) Cost-effectiveness analysis of pertuzumab with trastuzumab and chemotherapy compared to trastuzumab and chemotherapy in the adjuvant treatment of HER2-positive breast cancer in the United States. Value Health 22(4):408\u2013415","journal-title":"Value Health"},{"issue":"3","key":"12707_CR31","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1002\/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O","volume":"9","author":"CJ Murray","year":"2000","unstructured":"Murray CJ, Evans DB, Acharya A, Baltussen RM (2000) Development of WHO guidelines on generalized cost-effectiveness analysis. Health Econ 9(3):235\u2013251","journal-title":"Health Econ"},{"issue":"4","key":"12707_CR32","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/SLA.0b013e31826fd541","volume":"257","author":"H Yasunaga","year":"2013","unstructured":"Yasunaga H, Horiguchi H, Kuwabara K, Matsuda S, Fushimi K, Hashimoto H, Ayanian JZ (2013) Outcomes after laparoscopic or open distal gastrectomy for early-stage gastric cancer: a propensity-matched analysis. Ann Surg 257(4):640\u2013646","journal-title":"Ann Surg"},{"issue":"9813","key":"12707_CR33","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, Chung HC, Park YK, Lee KH, Lee KW, Kim YH, Noh SI, Cho JY, Mok YJ, Kim YH, Ji J, Yeh TS, Button P, Sirz\u00e9n F, Noh SH (2012) Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet (Lond, Engl) 379(9813):315\u2013321","journal-title":"Lancet (Lond, Engl)"},{"issue":"5","key":"12707_CR34","first-page":"516","volume":"27","author":"TX Wei","year":"2024","unstructured":"Wei TX, Wu ZQ, Ji JF (2024) Impact and intervention of postoperative complications after gastric cancer surgery from a health economics perspective. Zhonghua Wei Chang Wai Ke Za Zhi 27(5):516\u2013520","journal-title":"Zhonghua Wei Chang Wai Ke Za Zhi"},{"issue":"10","key":"12707_CR35","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1001\/jamasurg.2017.1718","volume":"152","author":"LV Selby","year":"2017","unstructured":"Selby LV, Gennarelli RL, Schnorr GC, Solomon SB, Schattner MA, Elkin EB, Bach PB, Strong VE (2017) Association of hospital costs with complications following total gastrectomy for gastric adenocarcinoma. JAMA Surg 152(10):953\u2013958","journal-title":"JAMA Surg"}],"container-title":["Surgical Endoscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12707-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00464-026-12707-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00464-026-12707-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:46:09Z","timestamp":1782859569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00464-026-12707-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["12707"],"URL":"https:\/\/doi.org\/10.1007\/s00464-026-12707-7","relation":{},"ISSN":["0930-2794","1432-2218"],"issn-type":[{"value":"0930-2794","type":"print"},{"value":"1432-2218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Min Lai, Qingqing Qin, Yanting Li and Wenzhen Yuan have no conflicts of interest or financial ties to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article is based on prior research and does not involve any new studies with human participants or animals conducted by the authors. Therefore, it does not require approval from an independent ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}}]}}